Metraipolis › archive › dc_57d74882a67c

From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics — Europe PMC PMID:41210172

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41210172
DOI
10.1016/j.omtm.2025.101613
License (as archived)
solo-consultazione
Archived
2026-11-09T10:02:01.456Z
SHA-256 of the archived text
42ee7168dfe951884aa8e02e824e6617cc9765536d6e0d0873b83f891f546ac4
Stable URL of this page
https://metraipolis.com/documento/dc_57d74882a67c

How to cite

From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics — Europe PMC PMID:41210172 — Europe PMC (en), https://europepmc.org/article/MED/41210172 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57d74882a67c (Metraipolis archive dc_57d74882a67c, sha256 42ee7168dfe951884aa8e02e824e6617cc9765536d6e0d0873b83f891f546ac4)
BibTeX
@misc{dc57d74882a67c,
  title = {From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics — Europe PMC PMID:41210172},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41210172},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57d74882a67c; sha256 42ee7168dfe951884aa8e02e824e6617cc9765536d6e0d0873b83f891f546ac4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41210172. Agents can read the archived copy with the MCP tool read_document.